Alterations in tau protein metabolism during normal aging

Area of Science:

• Neuroscience
• Aging Research
• Alzheimer's Disease Pathogenesis

Background:

• The relationship between normal aging and Alzheimer's disease (AD) remains unclear.
• Tau protein redistribution into paired helical filaments (PHFs) is characteristic of AD.
• Changes in tau protein distribution during normal aging are not well understood.

Purpose of the Study:

• To investigate age-related changes in tau protein distribution in the aging human brain.
• To compare tau protein changes in normal aging with those observed in Alzheimer's disease.
• To determine if age-related tau loss is linked to neurofibrillary or beta-amyloid pathology.

Main Methods:

• Examined PHF-bound and normal tau fractions in multiple brain regions (frontal, temporal, parietal, occipital neocortex, cerebellum, hippocampus, entorhinal cortex).
• Analyzed samples from 15 cognitively unimpaired individuals aged 19-88 years.
• Quantified tau protein levels and correlated them with age and neuropathological markers.

Main Results:

• Insoluble tau protein in the PHF fraction did not increase with aging, despite some neurofibrillary pathology in older individuals.
• Normal tau protein significantly decreased with aging (average loss of 14% per decade after age 20).
• Age-related tau loss was most pronounced in the frontal grey matter and hippocampus, unrelated to AD pathology.

Conclusions:

• The mechanisms of tau loss in normal aging and Alzheimer's disease appear distinct.
• Age-related tau protein loss, particularly in vulnerable brain regions, may contribute to cognitive impairments in non-demented elderly individuals.
• Findings suggest aging and AD may not be on the same continuum regarding tau pathology mechanisms.